Stay updated on Antiplatelet vs rtPA in Mild Stroke Clinical Trial
Sign up to get notified when there's something new on the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page.

Latest updates to the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a new build of the page. This update appears to be a metadata or formatting change rather than a modification to the study details.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a software update to the ClinicalTrials.gov interface. This update seems to modify the underlying system without altering the study content.SummaryDifference0.1%

- Check46 days agoChange DetectedPlatform/template update from v3.5.0 to v3.5.2; trial details, eligibility criteria, and study results remain unchanged.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision history updated: added Revision: v3.5.0 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check110 days agoChange DetectedAdded a new site revision tag (v3.4.2); removed a government-funding notice and an older revision tag (v3.4.1).SummaryDifference0.4%

- Check117 days agoChange DetectedAdded a government funding notice banner and updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Antiplatelet vs rtPA in Mild Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page.